Generic medicines: issues and relevance for global health

被引:16
|
作者
Rana, Proteesh [1 ]
Roy, Vandana [1 ]
机构
[1] Maulana Azad Med Coll, Pharmacol, New Delhi, India
关键词
free trade agreement; generic medicines; patents; DRUGS; PHYSICIAN; IMPACT; SUBSTITUTION; PREVENTION;
D O I
10.1111/fcp.12155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Generic medicine is a pharmaceutical product which is bioequivalent to the innovator product in terms of dosage form, strength, route of administration, quality, safety, performance characteristics, and intended use. Generic medicines are a cornerstone for providing affordable medicines to patients. The major generic markets in the world include United States of America followed by European Union, Canada, Japan, and Australia. The major suppliers of generic medicines China and India are showing tremendous growth in the generic medicine sector. There are many legal and regulatory issues along with quality concerns associated with the use of the generic products. Lately, bilateral international agreements called free trade agreements, delaying tactics by originator companies like strategic patenting and litigations on generic manufacturers, have been a major setback for the generic medicine industry. These issues need to be addressed to optimize the use of generic medicines. The sustainability of generic medicine sector is crucial for improving access to essential medicines for the worldwide.
引用
收藏
页码:529 / 542
页数:14
相关论文
共 50 条
  • [1] Global generic medicines - Health network communications' second annual summit
    Burck, Benjamin
    IDRUGS, 2008, 11 (05) : 328 - 330
  • [2] Conceptualising global health: theoretical issues and their relevance for teaching
    Mike Rowson
    Chris Willott
    Rob Hughes
    Arti Maini
    Sophie Martin
    J Jaime Miranda
    Vicki Pollit
    Abi Smith
    Rae Wake
    John S Yudkin
    Globalization and Health, 8
  • [3] Conceptualising global health: theoretical issues and their relevance for teaching
    Rowson, Mike
    Willott, Chris
    Hughes, Rob
    Maini, Arti
    Martin, Sophie
    Jaime Miranda, J.
    Pollit, Vicki
    Smith, Abi
    Wake, Rae
    Yudkin, John S.
    GLOBALIZATION AND HEALTH, 2012, 8
  • [4] Switching to different generic medicines: a checklist for safety issues
    Becker, Matthijs L.
    Al Hadithy, Asmar F. Y.
    van den Bemt, Patricia M. L. A.
    Hunfeld, Nicole G. M.
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (02): : 74 - 77
  • [5] Training in immunology of relevance to global health issues in resource poor settings
    Parida, Shreemanta K.
    Magalhaes, Isabelle
    Dubois, Patrice
    Janetzki, Sylvia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (05) : 1228 - 1231
  • [6] Value of generic medicines: an health economics study
    Martin Albrecht
    Ariane Höer
    Anne Zimmermann
    Journal of Pharmaceutical Policy and Practice, 8 (Suppl 1)
  • [7] Public health issues with counterfeit medicines
    Feldschreiber, Peter
    CLINICAL MEDICINE, 2009, 9 (01) : 63 - 64
  • [8] Generic medicines are not substandard medicines
    Ford, N
    't Hoen, E
    LANCET, 2002, 359 (9314): : 1351 - 1351
  • [9] Generic medicines
    Pearce, Greg
    AUSTRALIAN PRESCRIBER, 2007, 30 (04) : 88 - 90
  • [10] Pharmacological thoughts on generic medicines. Relevance of the concept of bioequivalence in antiepileptic drugs
    Azanza, J. R.
    Sadaba, B.
    Manubens, A.
    Quetglas, E.
    NEUROLOGIA, 2008, : 2 - 10